ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
S hares of KALA BIO (KALA) have been struggling lately and have lost 17.1% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback